Refractory Mycosis Fungoides and Sezary Syndrome

DBCOND0109359LymphomasRetroviridae Infections

Refractory Mycosis Fungoides and Sezary Syndrome is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
refractory Mycosis Fungoides/Sezary Syndrome · Mycosis fungoides/Sezary syndrome refractory
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10011679UMLSC0862204

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Refractory Mycosis Fungoides and Sezary Syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In